Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
vicr's Profile
Displaying 1-50 of 77 result(s).
CYDY CytoDyn Inc
11/24/2020 11:24:23 AM
Not sure if this WSJ article was po
CYDY CytoDyn Inc
10/13/2020 9:03:18 AM
Respert24, good points. For me, I g (3)
CYDY CytoDyn Inc
09/16/2020 10:53:20 PM
The road to any drug approval is a (6)
CYDY CytoDyn Inc
09/10/2020 5:55:23 PM
As you said the text appears to lea
CYDY CytoDyn Inc
09/10/2020 5:44:50 PM
I think the 6 day wait is to spread (4)
CYDY CytoDyn Inc
09/02/2020 7:52:02 PM
Hi CDiddy, I thought the call was g
CYDY CytoDyn Inc
08/29/2020 12:20:13 PM
I think CYDY's "diversion" into COV (3)
CYDY CytoDyn Inc
08/27/2020 6:15:59 PM
And Dr. Drew mentioning Leronlimab (2)
CYDY CytoDyn Inc
08/26/2020 7:39:49 PM
CTMedic, I am very interested in th
CYDY CytoDyn Inc
08/23/2020 3:00:38 PM
I think the odds are low that the a
CYDY CytoDyn Inc
08/20/2020 12:07:25 PM
I really like this point CDiddy. Th
CYDY CytoDyn Inc
08/13/2020 7:08:01 PM
Of course, it's great folks are try (2)
CYDY CytoDyn Inc
08/13/2020 2:04:50 PM
CDiddy, Thank you. I would leave of (2)
CYDY CytoDyn Inc
08/12/2020 9:03:24 PM
Did Leronlimab reduce the number o
CYDY CytoDyn Inc
08/11/2020 8:56:38 PM
For me, today's efficacy data stren (12)
CYDY CytoDyn Inc
08/09/2020 3:41:10 PM
Looking up the drug, Trodelvy, sugg (4)
CYDY CytoDyn Inc
08/09/2020 10:17:00 AM
TechGuru, Excellent post to help se (3)
CYDY CytoDyn Inc
08/07/2020 6:48:35 PM
The HIV submission to UK along with (2)
CYDY CytoDyn Inc
08/05/2020 5:41:01 PM
As Dr. J and DP and others have com (1)
CYDY CytoDyn Inc
08/03/2020 11:08:53 PM
Regarding stock grants. If its like (3)
CYDY CytoDyn Inc
08/03/2020 4:18:47 PM
Fred, So, IMMU is an example of a s
CYDY CytoDyn Inc
08/02/2020 6:58:43 PM
blafarm, Thank you. Yes, I believe (1)
CYDY CytoDyn Inc
08/02/2020 4:17:34 PM
TechGuru, I am more excited about D
CYDY CytoDyn Inc
08/02/2020 4:12:52 PM
Blafarm, Thank you for the excellen
CYDY CytoDyn Inc
08/02/2020 10:33:26 AM
Based on Dr. Yo's interview, I woul (1)
CYDY CytoDyn Inc
08/02/2020 10:30:41 AM
I would guess DP is closer to 55-57
CYDY CytoDyn Inc
08/01/2020 10:31:56 PM
One of the most interesting things (1)
CYDY CytoDyn Inc
08/01/2020 7:54:05 PM
Probably my main concern is the spe (1)
CYDY CytoDyn Inc
08/01/2020 10:15:14 AM
really, I agree releasing the safet (1)
CYDY CytoDyn Inc
08/01/2020 9:41:42 AM
TechGuru, Are you suggesting they m
CYDY CytoDyn Inc
07/31/2020 11:14:13 AM
TechGuru, Did you discuss this stat (1)
CYDY CytoDyn Inc
07/30/2020 5:04:47 PM
In my opinion the news was huge. Up (10)
CYDY CytoDyn Inc
07/28/2020 5:40:55 PM
Is it possible to know if CYDY has (2)
CYDY CytoDyn Inc
07/23/2020 2:07:10 PM
DP talks about immune system exhaus (2)
CYDY CytoDyn Inc
07/22/2020 1:58:01 PM
Thanks. I thinks its hilarious the (2)
CYDY CytoDyn Inc
07/22/2020 1:52:18 PM
What about the meeting with FDA for
CYDY CytoDyn Inc
07/22/2020 10:44:09 AM
I agree, Dr. Kelly should be announ
CYDY CytoDyn Inc
07/22/2020 10:41:47 AM
Furthermore, I would not expect any (1)
CYDY CytoDyn Inc
07/22/2020 9:53:33 AM
It seems reasonable to sell 10-20 m (8)
CYDY CytoDyn Inc
07/20/2020 11:26:58 PM
I'm going to assume that BP wearing
CYDY CytoDyn Inc
07/20/2020 10:18:42 PM
Not having Leronlimab is like "cook
CYDY CytoDyn Inc
07/19/2020 11:33:29 PM
Dr. Patterson did not patent anythi (6)
CYDY CytoDyn Inc
07/18/2020 10:22:09 PM
As I mentioned yesterday, this ques (3)
CYDY CytoDyn Inc
07/18/2020 10:14:28 PM
My recollection is that he said the
CYDY CytoDyn Inc
07/17/2020 11:58:16 PM
Leronlimab mentioned in this new pa (2)
CYDY CytoDyn Inc
07/17/2020 8:59:16 PM
I'm just saying to schedule multipl (1)
CYDY CytoDyn Inc
07/17/2020 6:04:49 PM
It's been a nerve racking journey.
CYDY CytoDyn Inc
07/13/2020 8:49:58 PM
this is not correct. They said they (1)
CYDY CytoDyn Inc
07/09/2020 7:20:39 PM
I think people should temper their
CYDY CytoDyn Inc
07/04/2020 9:32:51 AM
If you watch Dr. Beens previous vid (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding the Growth of Investment in Mosaic Over Time
  • Legal Insight: Examining Recent Mergers of CEPO, EFIN, SQCF, TLGYF
  • Investors Invited to Join Fiserv, Inc. Securities Action
  • Brigham Young University Faces Investigation Over Data Breach
  • Univest Securities Completes $4.2 Million Offering for GSIW
  • Skechers U.S.A. Faces Class Action: Investor Insights and More
  • Revolutionizing DeFi: aPriori's Insights on Latency Challenges
  • Understanding the Implications of Recent Mergers for Shareholders
  • Legal Inquiry: Mergers and Acquisitions Affecting Shareholders
  • LivePerson Announces Recent Equity Incentive Awards Details
  • Exciting New Travel Deals Released by Travelzoo for Members
  • Kinross Gold Corporation Completes Sale of White Gold Shares
  • Investigation Launched for Data Breach Impacting NASCAR Fans
  • Easterly ROCMuni Fund Faces Legal Scrutiny: Investor Alert
  • Urgent Notice for XPLR Infrastructure Investors: Act Now
  • Discover Magnite's Impressive Growth Over the Past 5 Years
  • PharmAla Biotech Expands Operations with Strong Q3 Results
  • Discover the Innovative GREY'S ANATOMY™ EMERGE Collection Today
  • Nabors Industries Welcomes David Tudor to the Board of Directors
  • Edelson Lechtzin LLP Investigates Premier Health Data Breach
  • U.S. Strengthens Trade Laws Against Unfair Lumber Practices
  • Berklee College of Music Honors Oliver Charles with Scholarship
  • ECN Capital Plans Conference Call for Q2-2025 Financials
  • Barnes & Noble Education Faces Legal Inquiry into Stock Practices
  • Eshallgo Inc. Faces Nasdaq Compliance Challenge Ahead
  • Class Action Alert for Rocket Pharmaceuticals Investors
  • Fairfax Financial Hosts Conference Call for Second Quarter Insights
  • ECN Capital Plans to Discuss Second Quarter 2025 Results
  • PharmAla Reports Impressive Growth and Key Milestones Achieved
  • Legal Action on Behalf of XPLR Infrastructure Unit Holders
  • Fairfax Financial Schedules Conference Call for Earnings Review
  • Teamsters Local 79 Celebrate New Contract with Southern Glazer's
  • Understanding CRH Inc.'s Strong Performance and P/E Ratio
  • Tesla Stock Surges Following Important Trading Indicators
  • What Five Years of Ownership Could Mean for TRGP Investors
  • Fannie Mae to Release Financial Results and Host Webcast Event
  • Birks Group Inc. Reveals Fiscal Year 2025 Insights and Future Plans
  • Edelson Lechtzin LLP Investigates Data Breach at McKenzie Hospital
  • Fannie Mae Prepares for Key Financial Results Announcement
  • Teamsters Celebrate Landmark Contract at Southern Glazer's
  • Unlocking New Opportunities: ThreeD Capital's Bold Financing Plans
  • Understanding the Sarepta Therapeutics Class Action Lawsuit
  • Fortrea Holdings Inc. Faces Class Action Lawsuit Update
  • Reckitt Benckiser Group Investors: Class Action Details Explained
  • Petco Health and Wellness Faces Class Action Lawsuit: Details Inside
  • Alto Neuroscience Investors Alerted to Class Action Opportunities
  • Investors Alert: Class Action Lawsuit Against 3D Systems Corp
  • Levi & Korsinsky Informs PepGen Inc. Investors on Lawsuit
  • Biohaven Ltd. Class Action: Important Insights for Investors
  • Hims & Hers Health Faces Legal Action Over Securities Claims
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site